Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Hemodialysis
Open Access
- 31 October 2008
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 52 (4), 727-736
- https://doi.org/10.1053/j.ajkd.2008.05.029
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin SaturationJournal of the American Society of Nephrology, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseThe New England Journal of Medicine, 2006
- II. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in AdultsAmerican Journal of Kidney Diseases, 2006
- Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis PatientsJournal of the American Society of Nephrology, 2006
- Association of anemia with outcomes in men with moderate and severe chronic kidney diseaseKidney International, 2006
- Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis PopulationHypertension, 2005
- Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findingsAmerican Journal of Kidney Diseases, 2004
- Possible effects of antioxidant status on increased platelet aggregation in childhood iron‐deficiency anemiaPediatrics International, 2001
- Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parametersEuropean Journal of Haematology, 1994
- The adverse effect of iron repletion on the course of certain infections.BMJ, 1978